This article explains, in educational terms, guide extension catheter — how the technology works and where it fits. The specific combination of wires, balloons, atherectomy, and stents is determined by the interventional cardiologist based on lesion complexity, calcification, and overall clinical picture. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Coronary Artery Disease and Percutaneous Coronary Intervention
The specific combination of wires, balloons, atherectomy, and stents is determined by the interventional cardiologist based on lesion complexity, calcification, and overall clinical picture. Coronary artery disease develops when atherosclerotic plaque accumulates within the arteries that supply the heart muscle, gradually narrowing the lumen and limiting blood flow. Contemporary practice relies heavily on drug-eluting stents, which release an antiproliferative agent to limit the tissue overgrowth that can cause restenosis.
Guide Extension and Support Catheters
Guide extension catheters telescope through a guiding catheter to provide deep-vessel backup support during complex or tortuous PCI. This added support can improve device delivery when a lesion is distal, calcified, or difficult to reach. INVAMED's coronary portfolio includes guiding catheters, extension catheters, and microcatheters intended to support crossing and delivery in demanding anatomy. The need for extension support is judged case by case, since it depends on vessel geometry and the devices being delivered.
Design and Technical Notes
INVAMED groups its coronary portfolio around the sequence of a PCI case, offering access, lesion preparation, drug delivery, scaffolding, and closure devices. Dual antiplatelet therapy duration is individualized to the clinical presentation and the patient's bleeding risk. Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes.
Key Considerations
- Dual antiplatelet therapy duration is individualized to the clinical presentation and the patient's bleeding risk.
- All INVAMED coronary devices are intended for use by trained interventional cardiologists under fluoroscopic guidance and per the IFU.
- Manufacturer figures such as the reported sub-5% target lesion revascularization rate describe studied performance, not guaranteed outcomes.
Frequently Asked Questions
Does INVAMED make a drug-coated coronary balloon?
Yes. The Extender Drug Eluting PTCA Balloon Catheter carries a paclitaxel coating for local drug delivery, such as in-stent restenosis or small-vessel disease.
What is the regulatory status of these coronary devices?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
What drug does the ATLAS stent release?
According to INVAMED, the ATLAS DES elutes sirolimus at 1 microgram per square millimeter with a sustained controlled-release profile.
Clinical and Technical Context
According to INVAMED, clinical data for the ATLAS DES show target lesion revascularization rates below 5% at 12 months, a figure that reflects studied performance rather than an individual guarantee. Percutaneous coronary intervention (PCI) is a catheter-based approach that reaches the coronary arteries through a small arterial access point, typically the radial or femoral artery. Selection among platforms is made by the operator according to vessel size, lesion characteristics, and deliverability requirements. Because a drug-coated balloon leaves nothing behind, it is one option a clinician may weigh when a metallic implant is less desirable. During PCI a lesion is usually crossed with a guidewire, prepared with a balloon, and in most cases scaffolded with a stent that holds the vessel open. Wire selection is a hands-on decision made by the operator according to lesion morphology and crossing strategy. Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes. Plaque modification is typically a preparatory step, and its use is decided by the operator based on the calcium burden seen on imaging.
Related on INVAMED
- Coronary Artery Disease & Cardiac Interventions — product category
- Coronary and CTO Guidewires: Technology, Uses and Considerations
- Sirolimus-Eluting Stent Platform: Technology, Uses and Considerations
- Cobalt-Chromium and Stainless-Steel Stent Options Explained — A Technical Guide
Important Disclaimer
This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.